Allurion Technologies (ALUR.WS)

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

的Allurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share of common stock（ALUR.WS）股票pre-market的价格今天是，自市场最后关闭以来，反映出NaN%pre-market的变动。该公司市值为，日交易量为股。前一交易日收盘价为 。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Allurion Technologies股票的指南。